HomeHNSA • STO
add
Hansa Biopharma AB
Previous close
kr 23.68
Day range
kr 23.94 - kr 28.38
Year range
kr 19.58 - kr 57.30
Market cap
1.92B SEK
Avg Volume
122.13K
P/E ratio
-
Dividend yield
-
Primary exchange
STO
In the news
Financials
Income Statement
Revenue
Net income
| (SEK) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 32.34M | -35.85% |
Operating expense | 199.58M | -5.18% |
Net income | -276.92M | -122.50% |
Net profit margin | -856.37 | -246.86% |
Earnings per share | -4.08 | -72.88% |
EBITDA | -180.09M | -1.46% |
Effective tax rate | -1.03% | — |
Balance Sheet
Total assets
Total liabilities
| (SEK) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 405.28M | -44.64% |
Total assets | 800.64M | -21.35% |
Total liabilities | 1.39B | 17.25% |
Total equity | -589.83M | — |
Shares outstanding | 67.81M | — |
Price to book | -2.72 | — |
Return on assets | -51.90% | — |
Return on capital | -80.08% | — |
Cash Flow
Net change in cash
| (SEK) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -276.92M | -122.50% |
Cash from operations | -147.80M | 14.54% |
Cash from investing | 0.00 | -100.00% |
Cash from financing | -1.88M | 14.53% |
Net change in cash | -148.26M | 15.81% |
Free cash flow | -147.74M | -138.00% |
About
Founded
2007
Website
Employees
135
